Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0013 | 0 | 0.5 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0013 | 0 | 0.5 |
Schistosoma mansoni | transient receptor potential channel 4 | 0.0081 | 0.5289 | 0.5289 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.003 | 0.1313 | 0.1313 |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0053 | 0.315 | 0.315 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.003 | 0.1313 | 0.1313 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.1111 | 0.21 |
Echinococcus granulosus | transient receptor potential ion channel A | 0.0078 | 0.5078 | 0.5078 |
Schistosoma mansoni | hypothetical protein | 0.003 | 0.1313 | 0.1313 |
Schistosoma mansoni | transient receptor potential channel | 0.0053 | 0.315 | 0.315 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0013 | 0 | 0.5 |
Brugia malayi | Transient-receptor-potential like protein | 0.003 | 0.1321 | 1 |
Entamoeba histolytica | hypothetical protein | 0.003 | 0.1313 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0141 | 1 | 1 |
Echinococcus granulosus | transient receptor potential gamma protein | 0.0081 | 0.5289 | 0.5289 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0013 | 0 | 0.5 |
Echinococcus multilocularis | transient receptor potential gamma protein | 0.0081 | 0.5289 | 0.5289 |
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0053 | 0.315 | 0.315 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0013 | 0 | 0.5 |
Echinococcus granulosus | TRP transient receptor potential channel | 0.003 | 0.1321 | 0.1321 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.5289 | 1 |
Entamoeba histolytica | hypothetical protein | 0.003 | 0.1313 | 0.5 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0013 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.003 | 0.1313 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.2939 | 0.5558 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.1321 | 0.2498 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0013 | 0 | 0.5 |
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0053 | 0.315 | 0.315 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0013 | 0 | 0.5 |
Echinococcus multilocularis | transient receptor potential ion channel A | 0.0078 | 0.5078 | 0.5078 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0013 | 0 | 0.5 |
Schistosoma mansoni | transient receptor potential channel | 0.0081 | 0.5289 | 0.5289 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0013 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.003 | 0.1313 | 0.994 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.003 | 0.1313 | 0.1313 |
Echinococcus multilocularis | geminin | 0.0141 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.003 | 0.1313 | 0.5 |
Schistosoma mansoni | transient receptor potential channel | 0.0053 | 0.315 | 0.315 |
Schistosoma mansoni | hypothetical protein | 0.0141 | 1 | 1 |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0053 | 0.315 | 0.315 |
Echinococcus multilocularis | TRP (transient receptor potential) channel | 0.003 | 0.1321 | 0.1321 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.